Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CoviVac in Adults Aged 60 Years and Older
NCT05765773Phase 2Completed
- Start
- Jul 2021
- Primary completion
- Oct 2022
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of COVI-VAC in coronavirus disease 2019 (COVID-19). Started Jul 2021; status: completed.
02
Drugs
COVI-VAC
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05765773.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05765773.